{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:21:46Z","timestamp":1787023306028,"version":"build-2736575974"},"reference-count":212,"publisher":"Radiation Research Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiation Research"],"published-print":{"date-parts":[[2021,5,12]]},"DOI":"10.1667\/21-00064.1","type":"journal-article","created":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T00:30:43Z","timestamp":1627345843000},"source":"Crossref","is-referenced-by-count":10,"title":["Celebrating 60 Years of Accomplishments of the Armed Forces Radiobiology Research Institute1"],"prefix":"10.1667","volume":"196","author":[{"given":"Balazs J.","family":"Bene","sequence":"first","affiliation":[{"name":"Military Medical Operations Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William F.","family":"Blakely","sequence":"additional","affiliation":[{"name":"Scientific Research Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Burmeister","sequence":"additional","affiliation":[{"name":"Scientific Research Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynnette","family":"Cary","sequence":"additional","affiliation":[{"name":"Scientific Research Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suyog J.","family":"Chhetri","sequence":"additional","affiliation":[{"name":"Military Medical Operations Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Davis","sequence":"additional","affiliation":[{"name":"Scientific Research Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanchita P.","family":"Ghosh","sequence":"additional","affiliation":[{"name":"Scientific Research Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory P.","family":"Holmes-Hampton","sequence":"additional","affiliation":[{"name":"Scientific Research Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Iordanskiy","sequence":"additional","affiliation":[{"name":"Scientific Research Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Kalinich","sequence":"additional","affiliation":[{"name":"Scientific Research Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliann G.","family":"Kiang","sequence":"additional","affiliation":[{"name":"Scientific Research Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidya P.","family":"Kumar","sequence":"additional","affiliation":[{"name":"Scientific Research Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Joel","family":"Lowy","sequence":"additional","affiliation":[{"name":"Scientific Research Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Miller","sequence":"additional","affiliation":[{"name":"Scientific Research Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Naeem","sequence":"additional","affiliation":[{"name":"AFRRI Directorate"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Schauer","sequence":"additional","affiliation":[{"name":"Radiation Sciences Department, Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lien","family":"Senchak","sequence":"additional","affiliation":[{"name":"Military Medical Operations Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay K.","family":"Singh","sequence":"additional","affiliation":[{"name":"Scientific Research Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aure J.","family":"Stewart","sequence":"additional","affiliation":[{"name":"Military Medical Operations Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elih M.","family":"Velazquez","sequence":"additional","affiliation":[{"name":"Scientific Research Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mang","family":"Xiao","sequence":"additional","affiliation":[{"name":"Scientific Research Department"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1243","reference":[{"key":"200","doi-asserted-by":"crossref","unstructured":"TC Pellmar and S Rockwell \"Radiat Res.\" 163, \"Priority list of research areas for radiological nuclear threat countermeasures.\" 115 (2005)","DOI":"10.1667\/RR3283"},{"key":"190","doi-asserted-by":"crossref","unstructured":"M Moroni, TV Coolbaugh, E Lombardini, et al. \"Radiat Res.\" 176, \"Hematopoietic radiation syndrome in the Gottingen minipig.\" 89 (2011)","DOI":"10.1667\/RR2481.1"},{"key":"191","doi-asserted-by":"crossref","unstructured":"M Moroni, E Lombardini, R Salber, et al. \"PLoS One.\" 6, \"Hematological changes as prognostic indicators of survival: Similarities between Gottingen minipigs, humans, and other large animal models.\" e25210 (2011)","DOI":"10.1371\/journal.pone.0025210"},{"key":"193","unstructured":"TB Elliott, NE Deutz, J Gulani, et al. \"Comp Med.\" 64, \"Gastrointestinal acute radiation syndrome in Gottingen minipigs (Sus Scrofa Domestica).\" 456 (2014)"},{"key":"1","unstructured":"\"Defense's nuclear agency, 1947\u20131997.\" (2002)"},{"key":"2","unstructured":"SL Jones, KJ Glueck, SB Jerabek, et al. \"Multiservice tactics, techniques, and procedures for treatment of nuclear and radiological casualties. ATP 4-02.83 (FM 4-02.283)\/MCRP 4-11.1B\/NTRP 4-02.21\/AFMAN 44-161(I).\" (2014)"},{"key":"3","unstructured":"\"AFRRI historical report 1 October 1986\u201330 September 1987. AFRRI SP87-1.\""},{"key":"4","unstructured":"\"AFRRI historical report 1 October 1985\u201330 September 1986. AFRRI SP86-3.\""},{"key":"5","unstructured":"\"Minutes of the 36th Armed Forces Radiobiology Research Institute Board of Governors (AFRRI\/BOG) meeting.\" (1988)"},{"key":"6","unstructured":"\"Uniformed Services University of the Health Sciences Journal. 2000 Edition.\" (2000)"},{"key":"8","unstructured":"\"Uniformed Services University of the Health Sciences Journal. 2002 Edition.\" (2002)"},{"key":"9","unstructured":"\"AFRRI Form 331.\" (2007)"},{"key":"13","doi-asserted-by":"crossref","unstructured":"\"Nuclear posture review.\" (2018)","DOI":"10.1063\/pt.6.3.20180209a"},{"key":"23","unstructured":"DR Boreham, REJ Mitchell, W Lausoontornsiri, et al. \"The medical basis for radiation-accident preparedness: The clinical care of victims.\" \"Preliminary risk assessment of the Thailand accident: The experience of an international collaboration.\" 351 (2002)"},{"key":"27","unstructured":"PG Prasanna, H Loats, HM Gerstenberg, et al. \"AFRRI's gamma-ray, X-ray, and fission-neutron calibration curves for the lymphocyte dicentric assay: Application of a metaphase finder system. Special publication 02-1.\" 1 (2002)"},{"key":"52","unstructured":"UY Schaff, CY Koh, NI Ossetrova, et al. \"The medical basis for radiation-accident preparedness.\" \"SpinDxTM: A rapid, point-of-care biodosimetry platform that uses peripheral whole blood protein and leukocyte biomarkers.\" 371 (2013)"},{"key":"58","unstructured":"G Sigal, E Glezer, J Kenten, et al. \"The medical basis for radiation-accident preparedness.\" \"Biomarker-based radiation-dosimetry diagnostics.\" 375 (2013)"},{"key":"68","unstructured":"TM Fliedner, I Friesecke, K Beyrer, \"Medical management of radiation accidents\u2013Manual on the acute radiation syndrome.\" 1 (2001)"},{"key":"69","unstructured":"\"First-responders radiological assessment triage (for Windows) (WinFRAT). Version 0.7.6.0 beta.\" (2011)"},{"key":"74","unstructured":"\"Final report to the congressional defense committees in response the joint explanatory statement accompanying the Department of Defense appropriations Act.\" (2014)"},{"key":"77","unstructured":"\"Operations in chemical, biological, radiological, and nuclear environments. Department of Defense Joint Publication 3-11.\" (2018)"},{"key":"79","doi-asserted-by":"crossref","unstructured":"\"Mil Med.\" 182, \"Research on health effects of low-level ionizing radiation exposure: Opportunities for the Armed Forces Radiobiology Research Institute.\" 1675 (2017)","DOI":"10.7205\/MILMED-D-17-00314"},{"key":"80","doi-asserted-by":"crossref","unstructured":"EG. Daxon, \"AFRRI Technical Report 1993: 93-2.\" \"Protocol for monitoring Gulf War veterans with imbedded fragments of depleted uranium.\" (1993)","DOI":"10.21236\/ADA266856"},{"key":"81","doi-asserted-by":"crossref","unstructured":"EG Daxon and JH Musk \"AFRRI Technical Report 1993: 93-1.\" \"Assessment of the risks from embedded fragments of depleted uranium.\" (1993)","DOI":"10.21236\/ADA266856"},{"key":"82","unstructured":"EE Kearsley and EG Daxon \"AFRRI Technical Report 1993: 93-3.\" \"Depleted uranium: questions and answers.\" (1993)"},{"key":"83","unstructured":"CA Castro, KA Benson, V Bogo, et al. \"AFRRI Technical Report 1996: 96-3.\" \"Establishment of an animal model to evaluate the biological effects of intramuscularly embedded depleted uranium fragments.\" (1996)"},{"key":"88","unstructured":"DR. Livengood, \"AFRRI Technical Report; 1998.\" \"Health effects of embedded depleted uranium fragments: an Armed Forces Radiobiology Research Institute workshop.\" 98 (1998)"},{"key":"99","unstructured":"\"Policy on analysis of metal fragments removed from Department of Defense Personnel. Policy no. 07-029.\" (2007)"},{"key":"100","unstructured":"\"Screening and evaluation protocol for veterans with embedded fragments who served in Iraq and\/or Afghanistan post-September 11, 2001 VHA Directive 1303.01.\" (2017)"},{"key":"110","unstructured":"GD Ledney, TB Elliott, MM Moore, \"The biological basis of radiation protection practice.\" \"Modulations of mortality by tissue trauma and sepsis in mice after radiation injury.\" 202 (1992)"},{"key":"130","doi-asserted-by":"crossref","unstructured":"L Wang, M Zhai, B Lin, et al. \"Radiat Res.\" \"Peg-G-CSF and L-Citrulline combinational therapy for mitigating skin wound combined radiation injury in a mouse model.\" (2021)","DOI":"10.1667\/RADE-20-00151.1"},{"key":"135","unstructured":"GC Benjamin, M McGeary, SR McCutchen, \"Assessing medical preparedness to respond to a terrorist nuclear event: Workshop report.\" (2009)"},{"key":"136","unstructured":"EJ Hall and AJ Giaccia \"Radiobiology for the radiobiologist.\" (2012)"},{"key":"141","unstructured":"\"Neupogen(R) (filgrastim) injection for subcutaneous or intravenous use.\" (2015)"},{"key":"142","unstructured":"\"Neulasta(R) (pegfilgrastim) injection, for subcutaneous use.\" (2015)"},{"key":"143","unstructured":"\"Nplate(R) (romiplostim) for injection, for subcutaneous use.\" 2021"},{"key":"144","unstructured":"\"Leukine(R) (sargramostim) for injection, for subcutaneous or intravenous use.\" (2018)"},{"key":"151","doi-asserted-by":"crossref","unstructured":"SY Aghdam, D Kenchegowda, NK Sharma, et al. \"Int J Mol Sci.\" 2020, \"Dysregulated cardiac IGF-1 signaling and antioxidant response are associated with radiation sensitivity.\" 21","DOI":"10.3390\/ijms21145049"},{"key":"164","doi-asserted-by":"crossref","unstructured":"JA Rotolo, CS Fong, S Bodo, et al. \"JCI Insight.\" 2021, \"Anti-ceramide 6B5 scFv mitigates the lethal radiation GI syndrome independent of DNA repair.\" 145380","DOI":"10.1172\/jci.insight.145380"},{"key":"168","unstructured":"\"Guidance for industry: Product development under the Animal Rule.\" (2015)"},{"key":"176","doi-asserted-by":"crossref","unstructured":"AK Cheema, Y Li, M Girgis, et al. \"Metabolites.\" 2020, \"Alterations in tissue metabolite profiles with amifostine-prophylaxed mice exposed to gamma radiation.\" 10","DOI":"10.3390\/metabo10050211"},{"key":"195","unstructured":"S. Groesbeck, \"AFRRI's Application\u2013Maryland Historical Trust Determination Eligibility Award.\" (2011)"},{"key":"196","unstructured":"\"AFRRI pocket guide.\" (2011)"},{"key":"197","unstructured":"\"Medical management of radiological casualties.\" (2013)"},{"key":"198","unstructured":"\"Medical consequences of radiological and nuclear weapons.\" (2013)"},{"key":"199","unstructured":"\"Treatment of radiation injuries.\" (1990)"},{"key":"201","unstructured":"DG Jarrett, RG Sedlak, WE Dickerson, et al. \"Use of Prussian blue (RadiogardaseTM) for treatment of internal radiocesium contamination.\" 1 (2005)"},{"key":"202","unstructured":"\"Radiocesium RDD (radiation dispersal device) patient initial contact work sheet. AFRRI Form 335.\" (2004)"},{"key":"203","unstructured":"\"The pathophysiology of combined injury and trauma: Management of infectious complications in mass casualty situations.\" (1987)"},{"key":"204","unstructured":"\"The pathophysiology of combined injury and trauma: Radiation, burn, and trauma.\" (1985)"},{"key":"205","unstructured":"\"AFRRI adult\/pediatric field medical record. AFRRI Form 330.\" (2004)"},{"key":"207","unstructured":"\"Mobile first-responder radiological assessment triage (mFRAT) for smart phones: iphone and android.\" (2017)"},{"key":"208","unstructured":"\"Technology assessment and roadmap for the emergency radiation dose assessment program (UCRL-TR-215887).\" (2006)"},{"key":"209","unstructured":"\"Policy 03-012.\" \"Policy for the operation Iraqi freedom depleted uranium (DU) medical management.\" (2003)"},{"key":"61","doi-asserted-by":"crossref","unstructured":"M Moroni, TB Elliott, NE Deutz, et al. \"Int J Radiat Biol.\" 90, \"Accelerated hematopoietic syndrome after radiation doses bridging hematopoietic (H-ARS) and gastrointestinal (GI-ARS) acute radiation syndrome: Early hematological changes and systemic inflammatory response syndrome in minipig.\" 363 (2014)","DOI":"10.3109\/09553002.2014.892226"},{"key":"165","doi-asserted-by":"crossref","unstructured":"VK Singh, VL Newman, AN Berg, et al. \"Expert Opin Drug Discov.\" 10, \"Animal models for acute radiation syndrome drug discovery.\" 497 (2015)","DOI":"10.1517\/17460441.2015.1023290"},{"key":"29","doi-asserted-by":"crossref","unstructured":"H Romm, RC Wilkins, CN Coleman, et al. \"Radiat Res.\" 175, \"Biological dosimetry by the triage dicentric chromosome assay: potential implications for treatment of acute radiation syndrome in radiological mass casualties.\" 397 (2011)","DOI":"10.1667\/RR2321.1"},{"key":"114","doi-asserted-by":"crossref","unstructured":"KL Koenig, RE Goans, RJ Hatchett, et al. \"Ann Emerg Med.\" 45, \"Medical treatment of radiological casualties: current concepts.\" 643 (2005)","DOI":"10.1016\/j.annemergmed.2005.01.020"},{"key":"40","doi-asserted-by":"crossref","unstructured":"SA Amundson, MB Grace, CB McLeland, et al. \"Cancer Res.\" 64, \"Human in vivo radiation-induced biomarkers: gene expression changes in radiotherapy patients.\" 6368 (2004)","DOI":"10.1158\/0008-5472.CAN-04-1883"},{"key":"28","doi-asserted-by":"crossref","unstructured":"U Oestreicher, D Samaga, E Ainsbury, et al. \"Int J Radiat Biol.\" 93, \"RENEB intercomparisons applying the conventional Dicentric Chromosome Assay (DCA).\" 20 (2017)","DOI":"10.1080\/09553002.2016.1233370"},{"key":"37","doi-asserted-by":"crossref","unstructured":"MB Grace, CB McLeland, WF Blakely, \"Int J Radiat Biol.\" 78, \"Real-time quantitative RT-PCR assay of GADD45 gene expression changes as a biomarker for radiation biodosimetry.\" 1011 (2002)","DOI":"10.1080\/09553000210158056"},{"key":"137","doi-asserted-by":"crossref","unstructured":"VK Singh and TM Seed \"Int J Radiat Biol.\" 93, \"A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part I. Radiation sub-syndromes, animal models and FDA-approved countermeasures.\" 851 (2017)","DOI":"10.1080\/09553002.2017.1332438"},{"key":"140","doi-asserted-by":"crossref","unstructured":"VK Singh and TM Seed \"Drugs Today (Barc).\" 54, \"An update on sargramostim for treatment of acute radiation syndrome.\" 679 (2018)","DOI":"10.1358\/dot.2018.54.11.2899370"},{"key":"155","doi-asserted-by":"crossref","unstructured":"VK Singh, PL Romaine, TM Seed, \"Health Phys.\" 108, \"Medical countermeasures for radiation exposure and related injuries: characterization of medicines, FDA-approval status and inclusion into the Strategic National Stockpile.\" 607 (2015)","DOI":"10.1097\/HP.0000000000000279"},{"key":"169","doi-asserted-by":"crossref","unstructured":"VK Singh, VL Newman, PL Romaine, et al. \"Expert Rev Mol Diagn.\" 16, \"Use of biomarkers for assessing radiation injury and efficacy of countermeasures.\" 65 (2016)","DOI":"10.1586\/14737159.2016.1121102"},{"key":"62","doi-asserted-by":"crossref","unstructured":"VK Singh, S Kulkarni, OO Fatanmi, et al. \"Radiat Res.\" 185, \"Radioprotective efficacy of gamma-tocotrienol in nonhuman primates.\" 285 (2016)","DOI":"10.1667\/RR14127.1"},{"key":"113","doi-asserted-by":"crossref","unstructured":"JG Kiang and AO Olabisi \"Cell Biosci.\" 9, \"Radiation: a poly-traumatic hit leading to multi-organ injury.\" 25 (2019)","DOI":"10.1186\/s13578-019-0286-y"},{"key":"50","doi-asserted-by":"crossref","unstructured":"NI Ossetrova, P Stanton, K Krasnopolsky, et al. \"Health Phys.\" 115, \"Biomarkers for radiation biodosimetry and injury assessment after mixed-field (neutron and gamma) radiation in the mouse total-body irradiation model.\" 727 (2018)","DOI":"10.1097\/HP.0000000000000938"},{"key":"51","doi-asserted-by":"crossref","unstructured":"NI Ossetrova, P Stanton, K Krasnopolsky, et al. \"Health Phys.\" 115, \"Comparison of biodosimetry biomarkers for radiation dose and injury assessment after mixed-field (neutron and gamma) and pure gamma radiation in the mouse total-body irradiation model.\" 743 (2018)","DOI":"10.1097\/HP.0000000000000939"},{"key":"45","doi-asserted-by":"crossref","unstructured":"JG Kiang, JT Smith, SR Hegge, et al. \"Radiat Res.\" 189, \"Circulating cytokine\/chemokine concentrations respond to ionizing radiation doses but not radiation dose rates: granulocyte-colony stimulating factor and interleukin-18.\" 634 (2018)","DOI":"10.1667\/RR14966.1"},{"key":"22","doi-asserted-by":"crossref","unstructured":"PG Prasanna, ND Escalada, WF Blakely, \"Mutat Res.\" 466, \"Induction of premature chromosome condensation by a phosphatase inhibitor and a protein kinase in unstimulated human peripheral blood lymphocytes: a simple and rapid technique to study chromosome aberrations using specific whole-chromosome DNA hybridization probes for biological dosimetry.\" 131 (2000)","DOI":"10.1016\/S1383-5718(00)00011-5"},{"key":"21","doi-asserted-by":"crossref","unstructured":"T Miura and WF Blakely \"Cytometry A.\" 79, \"Optimization of calyculin A-induced premature chromosome condensation assay for chromosome aberration studies.\" 1016 (2011)","DOI":"10.1002\/cyto.a.21154"},{"key":"20","doi-asserted-by":"crossref","unstructured":"T Miura, A Nakata, K Kasai, et al. \"Radiat Prot Dosimetry.\" 159, \"A novel parameter, cell-cycle progression index, for radiation dose absorbed estimation in the premature chromosome condensation assay.\" 52 (2014)","DOI":"10.1093\/rpd\/ncu126"},{"key":"162","doi-asserted-by":"crossref","unstructured":"AN Shakhov, VK Singh, F Bone, et al. \"PLoS One.\" 7, \"Prevention and mitigation of acute radiation syndrome in mice by synthetic lipopeptide agonists of Toll-like receptor 2 (TLR2).\" e33044 (2012)","DOI":"10.1371\/journal.pone.0033044"},{"key":"116","doi-asserted-by":"crossref","unstructured":"Z Zou, H Sun, Y Su, et al. \"Radiat Res.\" 169, \"Progress in research on radiation combined injury in China.\" 722 (2008)","DOI":"10.1667\/RR1284.1"},{"key":"117","doi-asserted-by":"crossref","unstructured":"JG Kiang, W Jiao, LH Cary, et al. \"Radiat Res.\" 173, \"Wound trauma increases radiation-induced mortality by activation of iNOS pathway and elevation of cytokine concentrations and bacterial infection.\" 319 (2010)","DOI":"10.1667\/RR1892.1"},{"key":"60","doi-asserted-by":"crossref","unstructured":"JG Kiang, BR Garrison, TM Burns, et al. \"Cell Biosci.\" 2, \"Wound trauma alters ionizing radiation dose assessment.\" 20 (2012)","DOI":"10.1186\/2045-3701-2-20"},{"key":"133","doi-asserted-by":"crossref","unstructured":"JG Kiang, M Zhai, PJ Liao, et al. \"Oxid Med Cell Longev.\" 2014, \"Pegylated G-CSF inhibits blood cell depletion, increases platelets, blocks splenomegaly, and improves survival after whole-body ionizing irradiation but not after irradiation combined with burn.\" 481392 (2014)","DOI":"10.1155\/2014\/481392"},{"key":"166","doi-asserted-by":"crossref","unstructured":"VK Singh and AO Olabisi \"Expert Opin Drug Discov.\" 12, \"Nonhuman primates as models for the discovery and development of radiation countermeasures.\" 695 (2017)","DOI":"10.1080\/17460441.2017.1323863"},{"key":"154","doi-asserted-by":"crossref","unstructured":"VK Singh, VL Newman, PL Romaine, et al. \"Expert Opin Ther Pat.\" 24, \"Radiation countermeasure agents: an update (2011\u20132014).\" 1229 (2014)","DOI":"10.1517\/13543776.2014.964684"},{"key":"139","doi-asserted-by":"crossref","unstructured":"VK Singh, VL Newman, TM Seed, \"Cytokine.\" 71, \"Colony-stimulating factors for the treatment of the hematopoietic component of the acute radiation syndrome (H-ARS): a review.\" 22 (2015)","DOI":"10.1016\/j.cyto.2014.08.003"},{"key":"152","doi-asserted-by":"crossref","unstructured":"VP Kumar, S Biswas, NK Sharma, et al. \"Health Phys.\" 115, \"PEGylated IL-11 (BBT-059): A novel radiation countermeasure for hematopoietic acute radiation syndrome.\" 65 (2018)","DOI":"10.1097\/HP.0000000000000841"},{"key":"167","doi-asserted-by":"crossref","unstructured":"M Moroni, BF Ngudiankama, C Christensen, et al. \"Int J Radiat Oncol Biol Phys.\" 86, \"The Gottingen minipig is a model of the hematopoietic acute radiation syndrome: G-colony stimulating factor stimulates hematopoiesis and enhances survival from lethal total-body gamma-irradiation.\" 986 (2013)","DOI":"10.1016\/j.ijrobp.2013.04.041"},{"key":"187","doi-asserted-by":"crossref","unstructured":"LH Cary, BF Ngudiankama, RE Salber, et al. \"Radiat Res.\" 177, \"Efficacy of radiation countermeasures depends on radiation quality.\" 663 (2012)","DOI":"10.1667\/RR2783.1"},{"key":"129","doi-asserted-by":"crossref","unstructured":"JG Kiang, M Zhai, DL Bolduc, et al. \"Radiat Res.\" 188, \"Combined therapy of pegylated G-CSF and Alxn4100TPO improves survival and mitigates acute radiation syndrome after whole-body ionizing irradiation alone and followed by wound trauma.\" 476 (2017)","DOI":"10.1667\/RR14647.1"},{"key":"124","doi-asserted-by":"crossref","unstructured":"JG Kiang, M Zhai, PJ Liao, et al. \"Mediators Inflamm.\" 2017, \"Thrombopoietin receptor agonist mitigates hematopoietic radiation syndrome and improves survival after whole-body ionizing irradiation followed by wound trauma.\" 7582079 (2017)","DOI":"10.1155\/2017\/7582079"},{"key":"59","doi-asserted-by":"crossref","unstructured":"WF Blakely, DL Bolduc, J Debad, et al. \"Health Phys.\" 115, \"Use of proteomic and hematology biomarkers for prediction of hematopoietic acute radiation syndrome severity in baboon radiation models.\" 29 (2018)","DOI":"10.1097\/HP.0000000000000819"},{"key":"49","doi-asserted-by":"crossref","unstructured":"NI Ossetrova, DJ Sandgren, S Gallego, et al. \"Health Phys.\" 98, \"Combined approach of hematological biomarkers and plasma protein SAA for improvement of radiation dose assessment triage in biodosimetry applications.\" 204 (2010)","DOI":"10.1097\/HP.0b013e3181abaabf"},{"key":"43","doi-asserted-by":"crossref","unstructured":"WF Blakely, DJ Sandgren, V Nagy, et al. \"Radiat Prot Dosimetry.\" 159, \"Further biodosimetry investigations using murine partial-body irradiation model.\" 46 (2014)","DOI":"10.1093\/rpd\/ncu127"},{"key":"54","doi-asserted-by":"crossref","unstructured":"WF Blakely, NI Ossetrova, MH Whitnall, et al. \"Health Phys.\" 98, \"Multiple parameter radiation injury assessment using a nonhuman primate radiation model-biodosimetry applications.\" 153 (2010)","DOI":"10.1097\/HP.0b013e3181b0306d"},{"key":"48","doi-asserted-by":"crossref","unstructured":"NI Ossetrova and WF Blakely \"Int J Radiat Biol.\" 85, \"Multiple blood-proteins approach for early-response exposure assessment using an in vivo murine radiation model.\" 837 (2009)","DOI":"10.3109\/09553000903154799"},{"key":"73","doi-asserted-by":"crossref","unstructured":"DL Bolduc, V Villa, DJ Sandgren, et al. \"Comput Math Methods Med.\" 2014, \"Application of multivariate modeling for radiation injury assessment: a proof of concept.\" 685286 (2014)","DOI":"10.1155\/2014\/685286"},{"key":"120","doi-asserted-by":"crossref","unstructured":"GD Ledney and TB Elliott \"Health Phys.\" 98, \"Combined injury: factors with potential to impact radiation dose assessments.\" 145 (2010)","DOI":"10.1097\/01.HP.0000348466.09978.77"},{"key":"44","doi-asserted-by":"crossref","unstructured":"CT Ha, XH Li, D Fu, et al. \"PLoS One.\" 9, \"Circulating interleukin-18 as a biomarker of total-body radiation exposure in mice, minipigs, and nonhuman primates (NHP).\" e109249 (2014)","DOI":"10.1371\/journal.pone.0109249"},{"key":"132","doi-asserted-by":"crossref","unstructured":"NV Gorbunov and JG Kiang \"Int J Mol Sci.\" 18, \"Ghrelin therapy decreases incidents of intracranial hemorrhage in mice after whole-body ionizing irradiation combined with burn trauma.\" 1693 (2017)","DOI":"10.3390\/ijms18081693"},{"key":"103","doi-asserted-by":"crossref","unstructured":"HS. Kishi, \"Neurosurgery.\" 47, \"Effects of the \u201cspecial bomb\u201d: recollections of a neurosurgeon in Hiroshima, August 8\u201315, 1945.\" 441 (2000)","DOI":"10.1097\/00006123-200008000-00034"},{"key":"104","doi-asserted-by":"crossref","unstructured":"AV. Barabanova, \"Vojnosanit Pregl.\" 63, \"Significance of beta-radiation skin burns in Chernobyl patients for the theory and practice of radiopathology.\" 477 (2006)","DOI":"10.2298\/VSP0605477B"},{"key":"192","doi-asserted-by":"crossref","unstructured":"B Legesse, A Kaur, D Kenchegowda, et al. \"Int J Radiat Oncol Biol Phys.\" 103, \"Neulasta regimen for the hematopoietic acute radiation syndrome: Effects beyond neutrophil recovery.\" 935 (2019)","DOI":"10.1016\/j.ijrobp.2018.11.043"},{"key":"182","doi-asserted-by":"crossref","unstructured":"W Fendler, B Malachowska, K Meghani, et al. \"Sci Transl Med.\" 9, \"Evolutionarily conserved serum microRNAs predict radiation-induced fatality in nonhuman primates.\" eaal2408 (2017)","DOI":"10.1126\/scitranslmed.aal2408"},{"key":"156","doi-asserted-by":"crossref","unstructured":"VK Singh, M Garcia, TM Seed, \"Int J Radiat Biol.\" 93, \"A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part II. Countermeasures for limited indications, internalized radionuclides, emesis, late effects, and agents demonstrating efficacy in large animals with or without FDA IND status.\" 870 (2017)","DOI":"10.1080\/09553002.2017.1338782"},{"key":"71","doi-asserted-by":"crossref","unstructured":"DL Bolduc, WF Blakely, CH Olsen, et al. \"Radiat Prot Dosimetry.\" 186, \"Baboon radiation quality (mixed-field neutron and gamma, gamma alone) dose-response model systems: assessment of h-ars severity using haematologic biomarkerS.\" 15 (2019)","DOI":"10.1093\/rpd\/ncz048"},{"key":"12","doi-asserted-by":"crossref","unstructured":"M Port and M Abend \"Radiat Prot Dosimetry.\" 182, \"Clinical triage of radiation casualties\u2013the hematological module of the Bundeswehr Institute of Radiobiology.\" 90 (2018)","DOI":"10.1093\/rpd\/ncy141"},{"key":"11","doi-asserted-by":"crossref","unstructured":"M Majewski, M Rozgic, P Ostheim, et al. \"Health Phys.\" 119, \"A new smartphone application to predict hematologic acute radiation syndrome based on blood cell count changes\u2013the H-module App.\" 64 (2020)","DOI":"10.1097\/HP.0000000000001247"},{"key":"118","doi-asserted-by":"crossref","unstructured":"JG Kiang, JT Smith, G Cannon, et al. \"Cell Biosci.\" 10, \"Ghrelin, a novel therapy, corrects cytokine and NF-kB-AKT-MAPK network and mitigates intestinal injury induced by combined radiation and skin-wound trauma.\" 63 (2020)","DOI":"10.1186\/s13578-020-00425-z"},{"key":"111","doi-asserted-by":"crossref","unstructured":"JG Kiang and GD Ledney \"Oxid Med Cell Longev.\" 2013, \"Skin injuries reduce survival and modulate corticosterone, C-reactive protein, complement component 3, IgM, and prostaglandin E 2 after whole-body reactor-produced mixed field (n + gamma-photons) irradiation.\" 821541 (2013)","DOI":"10.1155\/2013\/821541"},{"key":"127","doi-asserted-by":"crossref","unstructured":"R Fukumoto, TM Burns, JG Kiang, \"PLoS One.\" 9, \"Ciprofloxacin enhances stress erythropoiesis in spleen and increases survival after whole-body irradiation combined with skin-wound trauma.\" e90448 (2014)","DOI":"10.1371\/journal.pone.0090448"},{"key":"126","doi-asserted-by":"crossref","unstructured":"JG Kiang, MN Anderson, JT Smith, \"Cell Biosci.\" 8, \"Ghrelin therapy mitigates bone marrow injury and splenocytopenia by sustaining circulating G-CSF and KC increases after irradiation combined with wound.\" 27 (2018)","DOI":"10.1186\/s13578-018-0225-3"},{"key":"119","doi-asserted-by":"crossref","unstructured":"JG Kiang, M Zhai, PJ Liao, et al. \"Oxid Med Cell Longev.\" 2014, \"Ghrelin therapy improves survival after whole-body ionizing irradiation or combined with burn or wound: amelioration of leukocytopenia, thrombocytopenia, splenomegaly, and bone marrow injury.\" 215858 (2014)","DOI":"10.1155\/2014\/215858"},{"key":"106","doi-asserted-by":"crossref","unstructured":"FA Valeriote and DG Baker \"Radiat Res.\" 22, \"The combined effects of thermal trauma and x-irradiation on early mortality.\" 693 (1964)","DOI":"10.2307\/3571550"},{"key":"7","doi-asserted-by":"crossref","unstructured":"J VanHorne-Sealy, B Livingston, L Alleman, \"Health Phys.\" 102, \"DoD's Medical Radiobiology Advisory Team: experts on the ground.\" 489 (2012)","DOI":"10.1097\/HP.0b013e31824acb08"},{"key":"10","doi-asserted-by":"crossref","unstructured":"H D\u00f6rr, M Abend, WF Blakely, et al. \"Radiat Res.\" 187, \"Using clinical signs and symptoms for medical management of radiation casualties\u20132015 NATO exercise.\" 273 (2017)","DOI":"10.1667\/RR14619.1"},{"key":"14","doi-asserted-by":"crossref","unstructured":"VP Kumar, S Stone, S Biswas, et al. \"Front Pharmacol.\" 11, \"Gamma tocotrienol protects mice from targeted thoracic radiation injury.\" 587970 (2020)","DOI":"10.3389\/fphar.2020.587970"},{"key":"15","doi-asserted-by":"crossref","unstructured":"WF Blakely, A Romanyukha, SM Hayes, et al. \"Radiat Prot Dosimetry.\" 172, \"U.S. Department of Defense multiple-parameter biodosimetry network.\" 58 (2016)","DOI":"10.1093\/rpd\/ncw295"},{"key":"16","doi-asserted-by":"crossref","unstructured":"N Dainiak, J Albanese, M Kaushik, et al. \"Radiat Prot Dosimetry.\" 186, \"Concepts of operations for a US dosimetry and biodosimetry network.\" 130 (2019)","DOI":"10.1093\/rpd\/ncy294"},{"key":"17","doi-asserted-by":"crossref","unstructured":"EE Milner, EG Daxon, MT Anastasio, et al. \"Health Phys.\" 110, \"Concepts of operations (CONOPS) for biodosimetry tools employed in operational environments.\" 370 (2016)","DOI":"10.1097\/HP.0000000000000470"},{"key":"18","unstructured":"WF Blakely, PG Prasanna, CJ Kolanko, et al. \"Stem Cells.\" 13, \"Application of the premature chromosome condensation assay in simulated partial-body radiation exposures: evaluation of the use of an automated metaphase-finder.\" S223 (1995)"},{"key":"19","doi-asserted-by":"crossref","unstructured":"PG Prasanna, CJ Kolanko, HM Gerstenberg, et al. \"Health Phys.\" 72, \"Premature chromosome condensation assay for biodosimetry: studies with fission-neutrons.\" 594 (1997)","DOI":"10.1097\/00004032-199704000-00011"},{"key":"24","doi-asserted-by":"crossref","unstructured":"CJ Kolanko, MD Pyle, J Nath, et al. \"Biotech Histochem.\" 75, \"In situ detection of a PCR-synthesized human pancentromeric DNA hybridization probe by color pigment immunostaining: application for dicentric assay automation.\" 91 (2000)","DOI":"10.3109\/10520290009064153"},{"key":"25","doi-asserted-by":"crossref","unstructured":"PR Martin, RE Berdychevski, U Subramanian, et al. \"Radiat Measure.\" 42, \"Sample tracking in an automated cytogenetic biodosimetry laboratory for radiation mass casualties.\" 1119 (2007)","DOI":"10.1016\/j.radmeas.2007.05.021"},{"key":"26","doi-asserted-by":"crossref","unstructured":"WF Blakely, CA Salter, PG Prasanna, \"Health Phys.\" 89, \"Early-response biological dosimetry\u2013recommended countermeasure enhancements for mass-casualty radiological incidents and terrorism.\" 494 (2005)","DOI":"10.1097\/01.HP.0000175913.36594.a4"},{"key":"30","doi-asserted-by":"crossref","unstructured":"RC Wilkins, H Romm, TC Kao, et al. \"Radiat Res.\" 169, \"Interlaboratory comparison of the dicentric chromosome assay for radiation biodosimetry in mass casualty events.\" 551 (2008)","DOI":"10.1667\/RR1272.1"},{"key":"31","doi-asserted-by":"crossref","unstructured":"RC Wilkins, H Romm, U Oestreicher, et al. \"Radiat Measure.\" 46, \"Biological dosimetry by the triage dicentric chromosome assay\u2013Further validation of international networking.\" 923 (2011)","DOI":"10.1016\/j.radmeas.2011.03.012"},{"key":"32","doi-asserted-by":"crossref","unstructured":"U Subramanian, B O'Brien, M McNamara, et al. \"Health Phys.\" 119, \"Automated dicentric aberration scoring for triage dose assessment: 60Co gamma ray dose-response at different dose rates.\" 52 (2020)","DOI":"10.1097\/HP.0000000000001285"},{"key":"33","doi-asserted-by":"crossref","unstructured":"WF Blakely, Z Carr, MC Chu, et al. \"Radiat Res.\" 171, \"WHO 1st consultation on the development of a global biodosimetry laboratories network for radiation emergencies (BioDoseNet).\" 127 (2009)","DOI":"10.1667\/RR1549.1"},{"key":"34","unstructured":"P Voisin, F Barquinero, B Blakely, et al. \"Cell Mol Biol (Noisy-le-grand).\" 48, \"Towards a standardization of biological dosimetry by cytogenetics.\" 501 (2002)"},{"key":"35","doi-asserted-by":"crossref","unstructured":"WF Blakely, AC Miller, MB Grace, et al. \"Adv Space Res.\" 31, \"Radiation biodosimetry: applications for spaceflight.\" 1487 (2003)","DOI":"10.1016\/S0273-1177(03)00085-1"},{"key":"36","doi-asserted-by":"crossref","unstructured":"WF Blakely, AC Miller, L Luo, et al. \"Mil Med.\" 167, \"Nucleic acid molecular biomarkers for diagnostic biodosimetry applications: use of the fluorogenic 5\u2032-nuclease polymerase chain reaction assay.\" 16 (2002)","DOI":"10.1093\/milmed\/167.suppl_1.16"},{"key":"38","doi-asserted-by":"crossref","unstructured":"MB Grace and WF Blakely \"Radiat Measure.\" 42, \"Transcription of five p53- and Stat-3-inducible genes after ionizing radiation.\" 1147 (2007)","DOI":"10.1016\/j.radmeas.2007.05.004"},{"key":"39","doi-asserted-by":"crossref","unstructured":"MB Grace, CB McLeland, SJ Gagliardi, et al. \"Clin Chem.\" 49, \"Development and assessment of a quantitative reverse transcription-PCR assay for simultaneous measurement of four amplicons.\" 1467 (2003)","DOI":"10.1373\/49.9.1467"},{"key":"41","doi-asserted-by":"crossref","unstructured":"PG Prasanna, WF Blakely, JM Bertho, et al. \"Radiat Res.\" 173, \"Synopsis of partial-body radiation diagnostic biomarkers and medical management of radiation injury workshop.\" 245 (2010)","DOI":"10.1667\/RR1993.1"},{"key":"42","doi-asserted-by":"crossref","unstructured":"WF Blakely, DJ Sandgren, V Nagy, et al. \"Radiat Measure.\" 46, \"Murine partial-body radiation exposure model for biodosimetry studies\u2013preliminary report.\" 898 (2011)","DOI":"10.1016\/j.radmeas.2011.05.006"},{"key":"46","doi-asserted-by":"crossref","unstructured":"D Kim, F Marchetti, Z Chen, et al. \"Sci Rep.\" 3, \"Nanosensor dosimetry of mouse blood proteins after exposure to ionizing radiation.\" 2234 (2013)","DOI":"10.1038\/srep02234"},{"key":"47","doi-asserted-by":"crossref","unstructured":"X Li, W Cui, L Hull, et al. \"Sci Rep.\" 10, \"IL-18 binding protein (IL-18BP) as a novel radiation countermeasure after radiation exposure in mice.\" 18674 (2020)","DOI":"10.1038\/s41598-020-75675-5"},{"key":"53","doi-asserted-by":"crossref","unstructured":"WF Blakely, NI Ossetrova, GL Manglapus, et al. \"Radiat Measure.\" 42, \"Amylase and blood cell-count hematological radiation-injury biomarkers in a rhesus monkey radiation model\u2013use of multiparameter and integrated biological dosimetry.\" 1164 (2007)","DOI":"10.1016\/j.radmeas.2007.05.013"},{"key":"55","doi-asserted-by":"crossref","unstructured":"NI Ossetrova, WF Blakely, V Nagy, et al. \"Radiat Prot Dosimetry.\" 172, \"Non-human primate total-body irradiation model with limited and full medical supportive care including filgrastim for biodosimetry and injury assessment.\" 174 (2016)","DOI":"10.1093\/rpd\/ncw176"},{"key":"56","doi-asserted-by":"crossref","unstructured":"NI Ossetrova, AM Farese, TJ MacVittie, et al. \"Radiat Measure.\" 42, \"The use of discriminant analysis for evaluation of early-response multiple biomarkers of radiation exposure using nonhuman primate 6-Gy whole-body radiation model.\" 1158 (2007)","DOI":"10.1016\/j.radmeas.2007.05.031"},{"key":"57","doi-asserted-by":"crossref","unstructured":"NI Ossetrova, DJ Sandgren, WF Blakely, \"Radiat Prot Dosimetry.\" 159, \"Protein biomarkers for enhancement of radiation dose and injury assessment in nonhuman primate total-body irradiation model.\" 61 (2014)","DOI":"10.1093\/rpd\/ncu165"},{"key":"63","doi-asserted-by":"crossref","unstructured":"WF Blakely, JP Madrid, DJ Sandgren, \"Health Phys.\" 99, \"Biodosimetry medical recording\u2013use of the Biodosimetry Assessment Tool.\" S184 (2010)","DOI":"10.1097\/HP.0b013e3181f26895"},{"key":"64","doi-asserted-by":"crossref","unstructured":"DJ Sandgren, CA Salter, IH Levine, et al. \"Health Phys.\" 99, \"Biodosimetry Assessment Tool (BAT) software-dose prediction algorithms.\" S171 (2010)","DOI":"10.1097\/HP.0b013e3181f0fe6c"},{"key":"65","doi-asserted-by":"crossref","unstructured":"M Moroni, M Port, J Gulani, et al. \"Health Phys.\" 111, \"Significance of bioindicators for early predictions on diagnosis and therapy of irradiated minipigs.\" 160 (2016)","DOI":"10.1097\/HP.0000000000000456"},{"key":"66","doi-asserted-by":"crossref","unstructured":"RE Goans and CJ Iddins \"Health Phys.\" 120, \"The neutrophil to lymphocyte ratio as a triage tool in criticality accidents.\" 410 (2021)","DOI":"10.1097\/HP.0000000000001342"},{"key":"67","doi-asserted-by":"crossref","unstructured":"S Hu, WF Blakely, FA Cucinotta, \"Health Phys.\" 109, \"HEMODOSE: A biodosimetry tool based on multi-type blood cell counts.\" 54 (2015)","DOI":"10.1097\/HP.0000000000000295"},{"key":"70","doi-asserted-by":"crossref","unstructured":"GL King, DJ Sandgren, JM Mitchell, et al. \"Comp Med.\" 68, \"System for scoring severity of acute radiation syndrome response in rhesus macaques (Macaca mulatta).\" 474 (2018)","DOI":"10.30802\/AALAS-CM-17-000106"},{"key":"72","doi-asserted-by":"crossref","unstructured":"DL Bolduc, R Bunger, M Moroni, et al. \"Radiat Prot Dosimetry.\" 172, \"Modeling H-ARS using hematological parameters: A comparison between the non-human primate and minipig.\" 161 (2016)","DOI":"10.1093\/rpd\/ncw159"},{"key":"75","doi-asserted-by":"crossref","unstructured":"AC Miller, J Gilstad, DJ Brenner, \"Mil Med.\" 182, \"Military global health engagement and low-dose ionizing radiation.\" 1677 (2017)","DOI":"10.7205\/MILMED-D-17-00142"},{"key":"76","doi-asserted-by":"crossref","unstructured":"ZS Patel, TJ Brunstetter, WJ Tarver, et al. \"NPJ Microgravity.\" 6, \"Red risks for a journey to the red planet: The highest priority human health risks for a mission to Mars.\" 33 (2020)","DOI":"10.1038\/s41526-020-00124-6"},{"key":"78","doi-asserted-by":"crossref","unstructured":"DJ. Brenner, \"Health Phys.\" 97, \"Extrapolating radiation-induced cancer risks from low doses to very low doses.\" 505 (2009)","DOI":"10.1097\/HP.0b013e3181ad7f04"},{"key":"84","doi-asserted-by":"crossref","unstructured":"TC Pellmar, AF Fuciarelli, JW Ejnik, et al. \"Toxicol Sci.\" 49, \"Distribution of uranium in rats implanted with depleted uranium pellets.\" 29 (1999)","DOI":"10.1093\/toxsci\/49.1.29"},{"key":"85","doi-asserted-by":"crossref","unstructured":"FF Hahn, RA Guilmette, MD Hoover, \"Environ Health Perspect.\" 110, \"Implanted depleted uranium fragments cause soft tissue sarcomas in the muscles of rats.\" 51 (2002)","DOI":"10.1289\/ehp.0211051"},{"key":"86","unstructured":"TC Pellmar, DO Keyser, C Emery, et al. \"Neurotoxicology.\" 20, \"Electrophysiological changes in hippocampal slices isolated from rats embedded with depleted uranium fragments.\" 785 (1999)"},{"key":"87","doi-asserted-by":"crossref","unstructured":"RW Leggett and TC Pellmar \"J Environ Radioact.\" 64, \"The biokinetics of uranium migrating from embedded DU fragments.\" 205 (2003)","DOI":"10.1016\/S0265-931X(02)00050-4"},{"key":"89","doi-asserted-by":"crossref","unstructured":"JF Kalinich and DE McClain \"Biotech Histochem.\" 76, \"Staining of intracellular deposits of uranium in cultured murine macrophages.\" 247 (2001)","DOI":"10.1080\/714028151"},{"key":"90","doi-asserted-by":"crossref","unstructured":"JF Kalinich, N Ramakrishnan, V Villa, et al. \"Toxicology.\" 179, \"Depleted uranium-uranyl chloride induces apoptosis in mouse J774 macrophages.\" 105 (2002)","DOI":"10.1016\/S0300-483X(02)00318-9"},{"key":"91","doi-asserted-by":"crossref","unstructured":"AC Miller, WF Blakely, D Livengood, et al. \"Environ Health Perspect.\" 106, \"Transformation of human osteoblast cells to the tumorigenic phenotype by depleted uranium-uranyl chloride.\" 465 (1998)","DOI":"10.1289\/ehp.98106465"},{"key":"92","doi-asserted-by":"crossref","unstructured":"AC Miller, K Brooks, J Smith, et al. \"Mol Cell Biochem.\" 255, \"Effect of the militarily-relevant heavy metals, depleted uranium and heavy metal tungsten-alloy on gene expression in human liver carcinoma cells (HepG2).\" 247 (2004)","DOI":"10.1023\/B:MCBI.0000007280.72510.96"},{"key":"93","doi-asserted-by":"crossref","unstructured":"AC Miller, K Brooks, M Stewart, et al. \"J Environ Radioact.\" 64, \"Genomic instability in human osteoblast cells after exposure to depleted uranium: delayed lethality and micronuclei formation.\" 247 (2003)","DOI":"10.1016\/S0265-931X(02)00053-X"},{"key":"94","doi-asserted-by":"crossref","unstructured":"AC Miller, M Stewart, K Brooks, et al. \"J Inorg Biochem.\" 91, \"Depleted uranium-catalyzed oxidative DNA damage: absence of significant alpha particle decay.\" 246 (2002)","DOI":"10.1016\/S0162-0134(02)00391-4"},{"key":"95","doi-asserted-by":"crossref","unstructured":"AC Miller, M Stewart, R Rivas, \"Biochimie.\" 91, \"DNA methylation during depleted uranium-induced leukemia.\" 1328 (2009)","DOI":"10.1016\/j.biochi.2009.03.010"},{"key":"96","doi-asserted-by":"crossref","unstructured":"AC Miller, M Stewart, R Rivas, et al. \"Radiat Measure.\" 42, \"Observation of radiation-specific damage in cells exposed to depleted uranium: hprt gene mutation frequency.\" 1029 (2007)","DOI":"10.1016\/j.radmeas.2007.05.022"},{"key":"97","doi-asserted-by":"crossref","unstructured":"CA Emond, VB Vergara, ED Lombardini, et al. \"Int J Toxicol.\" 34, \"Induction of rhabdomyosarcoma by embedded military-grade tungsten\/nickel\/cobalt not by tungsten\/nickel\/iron in the B6C3F1 mouse.\" 44 (2015)","DOI":"10.1177\/1091581814565038"},{"key":"98","doi-asserted-by":"crossref","unstructured":"JF Kalinich, CA Emond, TK Dalton, et al. \"Environ Health Perspect.\" 113, \"Embedded weapons-grade tungsten alloy shrapnel rapidly induces metastatic high-grade rhabdomyosarcomas in F344 rats.\" 729 (2005)","DOI":"10.1289\/ehp.7791"},{"key":"101","doi-asserted-by":"crossref","unstructured":"CA Emond and JF Kalinich \"Health Phys.\" 102, \"Biokinetics of embedded surrogate radiological dispersal device material.\" 124 (2012)","DOI":"10.1097\/HP.0b013e31823095e5"},{"key":"102","unstructured":"S. Iijima, \"Acta Pathol Jpn.\" 32, \"Pathology of atomic bomb casualties.\" 237 (1982)"},{"key":"105","doi-asserted-by":"crossref","unstructured":"EL Alpen and GE Sheline \"Ann Surg.\" 140, \"The combined effects of thermal burns and whole body X irradiation on survival time and mortality.\" 113 (1954)","DOI":"10.1097\/00000658-195407000-00013"},{"key":"107","unstructured":"B. Korlof, \"Acta Chir Scand Suppl.\" 209, \"Infection of burns. I. A bacteriological and clinical study of 99 cases. II. Animal experiments; burns and total body x-irradiation.\" 1 (1956)"},{"key":"108","doi-asserted-by":"crossref","unstructured":"JW Brooks, EI Evans, WT Ham, et al. \"Ann Surg.\" 136, \"The influence of external body radiation on mortality from thermal burns.\" 533 (1952)","DOI":"10.1097\/00000658-195209000-00018"},{"key":"109","doi-asserted-by":"crossref","unstructured":"H Baxter, JA Drummond, LG Stephens-Newsham, et al. \"Ann Surg.\" 137, \"Reduction of mortality in swine from combined total body radiation and thermal burns by streptomycin.\" 450 (1953)","DOI":"10.1097\/00000658-195304000-00004"},{"key":"112","doi-asserted-by":"crossref","unstructured":"GD Ledney, DA Stewart, ED Exum, et al. \"Acta Radiol Oncol.\" 20, \"Skin wound-enhanced survival and myelocytopoiesis in mice after whole-body irradiation.\" 29 (1981)","DOI":"10.3109\/02841868109130187"},{"key":"115","unstructured":"Z Lausevic, M Lausevic, J Trbojevic-Stankovic, et al. \"Can J Surg.\" 51, \"Predicting multiple organ failure in patients with severe trauma.\" 97 (2008)"},{"key":"121","doi-asserted-by":"crossref","unstructured":"JG Kiang, JT Smith, MN Anderson, et al. \"PLoS One.\" 12, \"Hemorrhage enhances cytokine, complement component 3, and caspase-3, and regulates microRNAs associated with intestinal damage after whole-body gamma-irradiation in combined injury.\" e0184393 (2017)","DOI":"10.1371\/journal.pone.0184393"},{"key":"122","doi-asserted-by":"crossref","unstructured":"I Brook, TB Elliott, RA Harding, et al. \"J Med Microbiol.\" 50, \"Susceptibility of irradiated mice to Bacillus anthracis sterne by the intratracheal route of infection.\" 702 (2001)","DOI":"10.1099\/0022-1317-50-8-702"},{"key":"123","doi-asserted-by":"crossref","unstructured":"TB Elliott, I Brook, RA Harding, et al. \"Antimicrob Agents Chemother.\" 46, \"Antimicrobial therapy for bacillus anthracis-induced polymicrobial infection in (60)Co gamma-irradiated mice.\" 3463 (2002)","DOI":"10.1128\/AAC.46.11.3463-3471.2002"},{"key":"125","doi-asserted-by":"crossref","unstructured":"JG Kiang and NV Gorbunov \"J Cell Sci Ther.\" 5, \"Bone marrow mesenchymal stem cells increases survival after ionizing irradiation combined with wound trauma: Characterization and therapy.\" 6 (2014)","DOI":"10.4172\/2157-7013.1000190"},{"key":"128","doi-asserted-by":"crossref","unstructured":"NV Gorbunov, DP McDaniel, M Zhai, et al. \"J Cell Mol Med.\" 19, \"Autophagy and mitochondrial remodelling in mouse mesenchymal stromal cells challenged with Staphylococcus epidermidis.\" 1133 (2015)","DOI":"10.1111\/jcmm.12518"},{"key":"131","doi-asserted-by":"crossref","unstructured":"J Kiang, J Smith, M Anderson, et al. \"Pharm Pharmacol Int J.\" 7, \"A novel therapy, using ghrelin with pegylated G-CSF, inhibits brain hemorrhage from ionizing radiation or combined radiation injury.\" 133 (2019)","DOI":"10.15406\/ppij.2019.07.00243"},{"key":"134","doi-asserted-by":"crossref","unstructured":"JG Kiang, M Zhai, B Lin, et al. \"Front Pharmacol.\" 12, \"Co-therapy of pegylated G-CSF and ghrelin for enhancing survival after exposure to lethal radiation.\" 628018 (2021)","DOI":"10.3389\/fphar.2021.628018"},{"key":"138","doi-asserted-by":"crossref","unstructured":"M Xiao and MH Whitnall \"Curr Mol Pharmacol.\" 2, \"Pharmacological countermeasures for the acute radiation syndrome.\" 122 (2009)","DOI":"10.2174\/1874467210902010122"},{"key":"145","doi-asserted-by":"crossref","unstructured":"VK Singh and TM Seed \"Expert Opin Drug Saf.\" 18, \"The efficacy and safety of amifostine for the acute radiation syndrome.\" 1077 (2019)","DOI":"10.1080\/14740338.2019.1666104"},{"key":"146","doi-asserted-by":"crossref","unstructured":"VK Singh and TM Seed \"Expert Opin Pharmacother.\" 21, \"Pharmacological management of ionizing radiation injuries: Current and prospective agents and targeted organ systems.\" 317 (2020)","DOI":"10.1080\/14656566.2019.1702968"},{"key":"147","doi-asserted-by":"crossref","unstructured":"VK Singh and TM Seed \"Drug Discov Today.\" 26, \"Entolimod as a radiation countermeasure for acute radiation syndrome.\" 17 (2021)","DOI":"10.1016\/j.drudis.2020.10.003"},{"key":"148","doi-asserted-by":"crossref","unstructured":"VK Singh and TM Seed \"Expert Opin Investig Drugs.\" 29, \"BIO 300: a promising radiation countermeasure under advanced development for acute radiation syndrome and the delayed effects of acute radiation exposure.\" 429 (2020)","DOI":"10.1080\/13543784.2020.1757648"},{"key":"149","doi-asserted-by":"crossref","unstructured":"VK Singh and M Hauer-Jensen \"Int J Mol Sci.\" 17, \"Gamma-tocotrienol as a promising countermeasure for acute radiation syndrome: Current status.\" e663 (2016)","DOI":"10.3390\/ijms17050663"},{"key":"150","doi-asserted-by":"crossref","unstructured":"VK Singh, EJ Ducey, DS Brown, et al. \"Int J Radiat Biol.\" 88, \"A review of radiation countermeasure work ongoing at the Armed Forces Radiobiology Research Institute.\" 296 (2012)","DOI":"10.3109\/09553002.2012.652726"},{"key":"153","doi-asserted-by":"crossref","unstructured":"SP Ghosh, S Kulkarni, K Hieber, et al. \"Int J Radiat Biol.\" 85, \"Gamma-tocotrienol, a tocol antioxidant as a potent radioprotector.\" 598 (2009)","DOI":"10.1080\/09553000902985128"},{"key":"157","doi-asserted-by":"crossref","unstructured":"VK Singh, BK Hanlon, PT Santiago, et al. \"Int J Radiat Biol.\" 93, \"A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part III. Countermeasures under early stages of development along with \u2018standard of care\u2019 medicinal and procedures not requiring regulatory approval for use.\" 885 (2017)","DOI":"10.1080\/09553002.2017.1332440"},{"key":"158","doi-asserted-by":"crossref","unstructured":"M Satyamitra, L Cary, D Dunn, et al. \"Sci Rep.\" 10, \"CDX-301: a novel medical countermeasure for hematopoietic acute radiation syndrome in mice.\" 1757 (2020)","DOI":"10.1038\/s41598-020-58186-1"},{"key":"159","doi-asserted-by":"crossref","unstructured":"AC Miller, R Rivas, R McMahon, et al. \"Int J Radiat Biol.\" 93, \"Radiation protection and mitigation potential of phenylbutyrate: delivered via oral administration.\" 907 (2017)","DOI":"10.1080\/09553002.2017.1350301"},{"key":"160","doi-asserted-by":"crossref","unstructured":"XH Li, SP Ghosh, CT Ha, et al. \"Radiat Res.\" 180, \"Delta-tocotrienol protects mice from radiation-induced gastrointestinal injury.\" 649 (2013)","DOI":"10.1667\/RR13398.1"},{"key":"161","doi-asserted-by":"crossref","unstructured":"VK Singh, EJ Ducey, OO Fatanmi, et al. \"Radiat Res.\" 177, \"CBLB613: A TLR 2\/6 agonist, natural lipopeptide of Mycoplasma arginini, as a novel radiation countermeasure.\" 628 (2012)","DOI":"10.1667\/RR2657.1"},{"key":"163","doi-asserted-by":"crossref","unstructured":"M Satyamitra, E Lombardini, T Peng, et al. \"Int J Toxicol.\" 32, \"Preliminary nonclinical toxicity, pharmacokinetics, and pharmacodynamics of ALXN4100TPO, a thrombopoietin receptor agonist, in CD2F1 mice.\" 100 (2013)","DOI":"10.1177\/1091581813482336"},{"key":"170","doi-asserted-by":"crossref","unstructured":"AK Cheema, KY Mehta, OO Fatanmi, et al. \"Int J Mol Sci.\" 19, \"A metabolomic and lipidomic serum signature from nonhuman primates administered with a promising radiation countermeasure, gamma-tocotrienol.\" 79 (2017)","DOI":"10.3390\/ijms19010079"},{"key":"171","doi-asserted-by":"crossref","unstructured":"AK Cheema, SD Byrum, NK Sharma, et al. \"Radiat Res.\" 190, \"Proteomic changes in mouse spleen after radiation-induced injury and its modulation by gamma-tocotrienol.\" 449 (2018)","DOI":"10.1667\/RR15008.1"},{"key":"172","doi-asserted-by":"crossref","unstructured":"AK Cheema, CP Hinzman, KY Mehta, et al. \"Int J Mol Sci.\" 19, \"Plasma derived exosomal biomarkers of exposure to ionizing radiation in nonhuman primates.\" 3427 (2018)","DOI":"10.3390\/ijms19113427"},{"key":"173","doi-asserted-by":"crossref","unstructured":"AK Cheema, Y Li, M Girgis, et al. \"Sci Rep.\" 9, \"Metabolomic studies in tissues of mice treated with amifostine and exposed to gamma-radiation.\" 15701 (2019)","DOI":"10.1038\/s41598-019-52120-w"},{"key":"174","doi-asserted-by":"crossref","unstructured":"AK Cheema, KY Mehta, MU Rajagopal, et al. \"Int J Mol Sci.\" 20, \"Metabolomic studies of tissue injury in nonhuman primates exposed to gamma-radiation.\" 3360 (2019)","DOI":"10.3390\/ijms20133360"},{"key":"175","doi-asserted-by":"crossref","unstructured":"AK Cheema, KY Mehta, PT Santiago, et al. \"Int J Mol Sci.\" 20, \"Pharmacokinetic and metabolomic studies with BIO 300, a nanosuspension of genistein, in a nonhuman primate model.\" 1231 (2019)","DOI":"10.3390\/ijms20051231"},{"key":"177","doi-asserted-by":"crossref","unstructured":"M Girgis, Y Li, J Ma, et al. \"Sci Rep.\" 10, \"Comparative proteomic analysis of serum from nonhuman primates administered BIO 300: a promising radiation countermeasure.\" 19343 (2020)","DOI":"10.1038\/s41598-020-76494-4"},{"key":"178","doi-asserted-by":"crossref","unstructured":"EL Pannkuk, EC Laiakis, VK Singh, et al. \"Sci Rep.\" 7, \"Lipidomic signatures of nonhuman primates with radiation-induced hematopoietic syndrome.\" 9777 (2017)","DOI":"10.1038\/s41598-017-10299-w"},{"key":"179","doi-asserted-by":"crossref","unstructured":"EL Pannkuk, EC Laiakis, AJ Fornace, et al. \"Health Phys.\" 115, \"A metabolomic serum signature from nonhuman primates treated with a radiation countermeasure, gamma-tocotrienol, and exposed to ionizing radiation.\" 3 (2018)","DOI":"10.1097\/HP.0000000000000776"},{"key":"180","doi-asserted-by":"crossref","unstructured":"EL Pannkuk, EC Laiakis, M Garcia, et al. \"Radiat Res.\" 190, \"Nonhuman primates with acute radiation syndrome: Results from a global serum metabolomics study after 7.2 Gy total-body irradiation.\" 576 (2018)","DOI":"10.1667\/RR15167.1"},{"key":"181","doi-asserted-by":"crossref","unstructured":"Y Li, J Singh, R Varghese, et al. \"Sci Rep.\" 18, \"Transcriptome of rhesus macaque (Macaca mulatta) exposed to total-body irradiation.\" 6295 (2021)","DOI":"10.21203\/rs.3.rs-128581\/v1"},{"key":"183","doi-asserted-by":"crossref","unstructured":"N Chakraborty, A Gautam, GP Holmes-Hampton, et al. \"Sci Rep.\" 10, \"microRNA and metabolite signatures linked to early consequences of lethal radiation.\" 5424 (2020)","DOI":"10.1038\/s41598-020-62255-w"},{"key":"184","doi-asserted-by":"crossref","unstructured":"XH Li, CT Ha, D Fu, et al. \"PLoS One.\" 10, \"Delta-tocotrienol suppresses radiation-induced microRNA-30 and protects mice and human CD34+ cells from radiation injury.\" e0122258 (2015)","DOI":"10.1371\/journal.pone.0122258"},{"key":"185","doi-asserted-by":"crossref","unstructured":"SP Ghosh, S Kulkarni, MW Perkins, et al. \"J Radiat Res.\" 53, \"Amelioration of radiation-induced hematopoietic and gastrointestinal damage by Ex-RAD(R) in mice.\" 526 (2012)","DOI":"10.1093\/jrr\/rrs001"},{"key":"186","doi-asserted-by":"crossref","unstructured":"GD Ledney, TB Elliott, RA Harding, et al. \"Int J Radiat Biol.\" 76, \"WR-151327 increases resistance to Klebsiella pneumoniae infection in mixed-field- and gamma-photon-irradiated mice.\" 261 (2000)","DOI":"10.1080\/095530000138916"},{"key":"188","doi-asserted-by":"crossref","unstructured":"NK Sharma, GP Holmes-Hampton, VP Kumar, et al. \"Sci Rep.\" 10, \"Delayed effects of acute whole body lethal radiation exposure in mice pre-treated with BBT-059.\" 6825 (2020)","DOI":"10.1038\/s41598-020-63818-7"},{"key":"189","doi-asserted-by":"crossref","unstructured":"NK Sharma, S Stone, VP Kumar, et al. \"Front Aging Neurosci.\" 11, \"Mitochondrial degeneration and autophagy associated with delayed effects of radiation in the mouse brain.\" 357 (2019)","DOI":"10.3389\/fnagi.2019.00357"},{"key":"194","doi-asserted-by":"crossref","unstructured":"A Kaur, GAM Ten Have, B Hritzo, et al. \"Int J Radiat Biol.\" 96, \"Morphological and functional impairment in the gut in a partial body irradiation minipig model of GI-ARS.\" 112 (2020)","DOI":"10.1080\/09553002.2018.1552377"},{"key":"206","doi-asserted-by":"crossref","unstructured":"RE. Goans, \"Health Phys.\" 99, \"Clinical application of the AFRRI BAT computer program.\" S192 (2010)","DOI":"10.1097\/HP.0b013e3181ebcef7"},{"key":"210","doi-asserted-by":"crossref","unstructured":"DE McClain, KA Benson, TK Dalton, et al. \"Sci Total Environ.\" 274, \"Biological effects of embedded depleted uranium (DU): summary of Armed Forces Radiobiology Research Institute Research.\" 115 (2001)","DOI":"10.1016\/S0048-9697(01)00734-3"},{"key":"211","doi-asserted-by":"crossref","unstructured":"RI. Walker, \"Pharmacol Ther.\" 39, \"Requirements of radioprotectors for military and emergency needs.\" 13 (1988)","DOI":"10.1016\/0163-7258(88)90034-4"},{"key":"212","doi-asserted-by":"crossref","unstructured":"MR Landauer and RW Young \"Mil Med.\" 167, \"Psychological consequences of military operations in low-level radiation environments.\" 139 (2002)","DOI":"10.1093\/milmed\/167.suppl_1.139"}],"container-title":["Radiation Research"],"original-title":[],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T23:35:27Z","timestamp":1725492927000},"score":1,"resource":{"primary":{"URL":"https:\/\/bioone.org\/journals\/radiation-research\/volume-196\/issue-2\/21-00064.1\/Celebrating-60-Years-of-Accomplishments-of-the-Armed-Forces-Radiobiology\/10.1667\/21-00064.1.full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,12]]},"references-count":212,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,8,1]]}},"URL":"https:\/\/doi.org\/10.1667\/21-00064.1","relation":{},"ISSN":["0033-7587"],"issn-type":[{"value":"0033-7587","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,12]]}}}